Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Current assets
Cash and equivalents	$ 2,318	$ 8,051
Receivables, less allowances of $100 and $117, respectively	2,877	2,518
Inventories	2,357	2,006
Other current assets	1,457	1,244
Total current assets	9,009	13,819
Property, plant and equipment, net	2,689	2,363
Other assets
Goodwill	17,964	14,480
Other intangible assets	10,976	6,263
Copeland note receivable and equity investment	3,191	3,255
Other	2,611	2,566
Total other assets	34,742	26,564
Total assets	46,440	42,746
Current liabilities
Short-term borrowings and current maturities of long-term debt	3,155	547
Accounts payable	1,271	1,275
Accrued expenses	3,238	3,210
Total current liabilities	7,664	5,032
Long-term debt	7,614	7,610
Other liabilities	4,381	3,506
Equity
Common stock, $0.50 par value; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 572.0 shares and 572.1 shares, respectively	477	477
Additional paid-in-capital	158	62
Retained earnings	40,108	40,070
Accumulated other comprehensive income (loss)	(1,097)	(1,253)
Cost of common stock in treasury, 381.4 shares and 381.3 shares, respectively	(18,746)	(18,667)
Common stockholders’ equity	20,900	20,689
Noncontrolling interests in subsidiaries	5,881	5,909
Total equity	26,781	26,598
Total liabilities and equity	$ 46,440	$ 42,746